Focus Partners Advisor Solutions LLC bought a new position in Danaher Corporation (NYSE:DHR - Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 13,430 shares of the conglomerate's stock, valued at approximately $2,558,000.
Other institutional investors have also recently bought and sold shares of the company. State Street Corp lifted its holdings in shares of Danaher by 1.7% during the 4th quarter. State Street Corp now owns 27,681,334 shares of the conglomerate's stock worth $6,345,529,000 after acquiring an additional 472,608 shares during the period. Capital International Investors increased its stake in Danaher by 8.9% in the fourth quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate's stock valued at $4,177,386,000 after acquiring an additional 1,487,768 shares during the period. Price T Rowe Associates Inc. MD raised its position in Danaher by 9.1% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 15,973,240 shares of the conglomerate's stock worth $3,656,595,000 after purchasing an additional 1,334,221 shares in the last quarter. Wellington Management Group LLP raised its position in Danaher by 11.2% in the fourth quarter. Wellington Management Group LLP now owns 15,076,796 shares of the conglomerate's stock worth $3,451,380,000 after purchasing an additional 1,517,904 shares in the last quarter. Finally, Norges Bank bought a new position in Danaher during the fourth quarter worth about $2,177,106,000. Institutional investors and hedge funds own 79.05% of the company's stock.
Danaher Stock Down 0.7%
NYSE DHR opened at $202.51 on Friday. The firm has a market cap of $142.37 billion, a PE ratio of 35.97, a price-to-earnings-growth ratio of 2.52 and a beta of 0.78. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80. The stock's 50 day simple moving average is $193.14 and its 200 day simple moving average is $193.21. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25.
Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating analysts' consensus estimates of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The firm had revenue of $6.26 billion during the quarter, compared to analysts' expectations of $6.12 billion. During the same period last year, the firm posted $0.77 EPS. The business's revenue was up 5.5% on a year-over-year basis. As a group, sell-side analysts forecast that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
A number of equities research analysts have weighed in on DHR shares. Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating and set a $240.00 price objective on shares of Danaher in a report on Wednesday, July 22nd. UBS Group cut their target price on Danaher from $270.00 to $250.00 and set a "buy" rating for the company in a research report on Wednesday, April 22nd. Wall Street Zen lowered Danaher from a "buy" rating to a "hold" rating in a research note on Saturday, April 25th. Wells Fargo & Company lowered their price target on Danaher from $212.00 to $195.00 and set an "equal weight" rating on the stock in a research report on Wednesday, July 22nd. Finally, Guggenheim dropped their price objective on Danaher from $235.00 to $200.00 and set a "buy" rating for the company in a research note on Wednesday, July 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have given a Hold rating to the stock. According to MarketBeat, Danaher presently has an average rating of "Moderate Buy" and a consensus target price of $228.91.
View Our Latest Analysis on Danaher
Danaher Company Profile
(
Free Report)
Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Further Reading
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
